TMO EPM / Hemato H9J

TMO EPM / Hemato H9J

Esplora temi rilevanti sulla Ematologia e sul Trapianto di Midollo Osseo con esperti della Scuola Paulista di Medicina e dell'Ospedale 9 di Luglio.

Listen on Apple Podcasts

54 - Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial

S1 E54 • 40 mins • Jun 2, 2025

Episodi recenti

Jun 2, 2025

54 - Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial

S1 E54 • 40 mins

May 2, 2025

53 - Daratumumab, carfilzomib, lenalidomide, and dexamethasone with tandem transplant for high-risk newly diagnosed myeloma

S1 E53 • 32 mins

Apr 29, 2025

52 - Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia

S1 E52 • 41 mins

Apr 13, 2025

51 - Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia

S1 E51 • 35 mins

Apr 7, 2025

50 - Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia

S1 E50 • 27 mins

Lingua
Portoghese
Paese
Brasile
Feed Host
Richiedi un aggiornamento
Gli aggiornamenti potrebbero richiedere alcuni minuti.